References
- Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.
- Zhang G, Li H, Huang W, et al. Clinical features of lupus cystitis complicated with hydroureteronephrosis in a Chinese population. J Rheumatol. 2011;38:667–671.
- Boye E, Morse M, Huttner I, et al. Immune complex-mediated interstitial cystitis as a major manifestation of systemic lupus erythematosus. Clin Immunol Immunopathol. 1979;13:67–76.
- Takabayashi K, Sueishi M, Tomioka H, et al. Lupus cystitis: a report of four cases (in Japanese). Nihon Naika Gakkai Zasshi. 1985;74:1579–1585.
- Koike T, Takabayashi K. Lupus cystitis in the Japanese. Intern Med. 1996;35:87–88.
- Koh JH, Lee J, Jung SM, et al. Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes. Lupus. 2015;24:1300–1307.
- Shimizu A, Tamura A, Tago O, et al. Lupus cystitis: a case report and review of the literature. Lupus. 2009;18:655–658.
- Casey RG, Catto JW, Cheng L, et al. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015;67:876–888.
- Chade DC, Shariat SF, Adamy A, et al. Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol. 2010;184:464–469.
- Farrow GM, Utz DC, Rife CC, et al. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res. 1977;37:2794–2798.
- Hayakawa N, Kikuchi E, Mikami S, et al. The clinical impact of the classification of carcinoma in situ on tumor recurrence and their clinical course in patients with bladder tumor. Jpn J Clin Oncol. 2011;41:424–429.
- Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239–249.
- Nishizaki Y, Tamaki H, Yukawa S, et al. Comparison between Japanese and non-Japanese features of lupus cystitis based on case reports including novel therapy and a literature review. Intern Med. 2011;50:961–968.
- Segawa C, Wada T, Furuichi K, et al. Steroid pulse therapy in lupus cystitis. Intern Med. 1996;35:155–158.
- Bai SW, Park SH, Chung DJ, et al. The significance of bladder trabeculation in the female lower urinary system: an objective evaluation by urodynamic studies. Yonsei Med J. 2005;46:673–678.
- Yukawa S, Tahara K, Hayashi H, et al. A case of lupus cystitis in a 74-year-old woman. Nihon Rinsho Meneki Gakkai Kaishi. 2008;31:183–189.
- Lenherr SM, Crosby EC, Cameron AP. Cystoscopic findings: a video tutorial. Int Urogynecol J. 2015;26:921–923.
- Kang KY, Kim HO, Yoon HS, et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol. 2010;29:381–388.
- Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum. 2011;63:3032–3037.
- Huang HB, Jiang SC, Han J, et al. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus. J Cancer Res Clin Oncol. 2014;140:1067–1073.
- Keller J, Chiou HY, Lin HC. Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2013;32:58–62.